102 related articles for article (PubMed ID: 2466019)
21. Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples.
Festuccia C; Angelucci A; Gravina GL; Muzi P; Miano R; Vicentini C; Bologna M
Int J Oncol; 2005 May; 26(5):1353-62. PubMed ID: 15809728
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous metastases. Report of two cases of prostatic cancer.
Landow RK; Rhodes DW; Bauer M
Cutis; 1980 Oct; 26(4):399-401, 409. PubMed ID: 7418439
[TBL] [Abstract][Full Text] [Related]
23. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
24. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines.
Webber MM; Bello D; Quader S
Prostate; 1996 Dec; 29(6):386-94. PubMed ID: 8977636
[TBL] [Abstract][Full Text] [Related]
25. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
Zhao J; Epstein JI
Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
[TBL] [Abstract][Full Text] [Related]
26. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer.
Ruiz M; Troncoso P; Bruns C; Bar-Eli M
Clin Cancer Res; 2001 Dec; 7(12):4086-95. PubMed ID: 11751506
[TBL] [Abstract][Full Text] [Related]
27. An unusual scalp swelling.
Koshy CE; Lyons B; Morris RJ
Br J Plast Surg; 2000 Jan; 53(1):80-1. PubMed ID: 10657459
[No Abstract] [Full Text] [Related]
28. Applications of immunohistochemistry to the diagnosis and prognostication of prostate carcinoma and prostatic intraepithelial neoplasia.
Maygarden SJ
Pathol Annu; 1994; 29 Pt 1():303-20. PubMed ID: 7510385
[No Abstract] [Full Text] [Related]
29. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
Spieler P; Gloor F
Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
[TBL] [Abstract][Full Text] [Related]
30. Immunohistologic diagnosis of 2 cases of metastatic prostate cancer to breast.
Naritoku WY; Taylor CR
J Urol; 1983 Aug; 130(2):365-7. PubMed ID: 6192256
[TBL] [Abstract][Full Text] [Related]
31. PSA and PAP as immunohistochemical markers in prostate cancer.
Epstein JI
Urol Clin North Am; 1993 Nov; 20(4):757-70. PubMed ID: 7505984
[TBL] [Abstract][Full Text] [Related]
32. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
Gong Y; Booser DJ; Sneige N
Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
[TBL] [Abstract][Full Text] [Related]
33. Scrotal and penile papules and plaques as the initial manifestation of a cutaneous metastasis of adenocarcinoma of the prostate: case report and review of the literature.
Wang SQ; Mecca PS; Myskowski PL; Slovin SF
J Cutan Pathol; 2008 Jul; 35(7):681-4. PubMed ID: 18201228
[TBL] [Abstract][Full Text] [Related]
34. Phyllodes tumor of the prostate: long-term followup study of 23 cases.
Bostwick DG; Hossain D; Qian J; Neumann RM; Yang P; Young RH; di Sant'agnese PA; Jones EC
J Urol; 2004 Sep; 172(3):894-9. PubMed ID: 15310992
[TBL] [Abstract][Full Text] [Related]
35. [Rare association of a mixed tumor of the skin with a carcinoma of low grade malignancy. Clinical case].
Riboni V; Segato G; Kalamian H; Orsini C; Vespa D; Bonoldi M; Meli S
Minerva Chir; 1996; 51(7-8):617-20. PubMed ID: 8975167
[TBL] [Abstract][Full Text] [Related]
36. Skin clues to primary and metastatic malignancy.
Cohen PR
Am Fam Physician; 1995 Apr; 51(5):1199-204. PubMed ID: 7709895
[TBL] [Abstract][Full Text] [Related]
37. The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage.
Meid FH; Gygi CM; Leisinger HJ; Bosman FT; Benhattar J
J Urol; 2001 May; 165(5):1802-5. PubMed ID: 11342979
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
39. Skin metastases from unknown origin: role of immunohistochemistry in the evaluation of cutaneous metastases of carcinoma of unknown origin.
Azoulay S; Adem C; Pelletier FL; Barete S; Francès C; Capron F
J Cutan Pathol; 2005 Sep; 32(8):561-6. PubMed ID: 16115055
[TBL] [Abstract][Full Text] [Related]
40. Value of different markers in prostatic carcinomas. An immunohistological study.
Daher N; Bove N; Bara J; Abourachid H
Prog Clin Biol Res; 1987; 243A():507-10. PubMed ID: 2443921
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
